Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
307. Steinberg E.P. et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography // N. Engl. J. Med. -1992.-Vol. 326.-P. 425.
308. CaroJJ. etal. The risk of death and of severe nonfatal reactions with high-versus low-osmolality contrast media: a meta-analysis // AJR. - 1991. - Vol. 156. - P. 825.
309. ShellockF.G. etal. Adverse reaction to intravenous gadoteridol // Radiology. - 1993. - Vol. 189 -P. 151.
310. Greenberger PA., Patterson R. TTie prevention of immediate generalized reactions to radiocontrast media in high-risk patients 11 J. Allergy Clin. Immunol. - 1991. - Vol. 87. - P. 867.
311. Siegle R.L. et al. The use of iohexal in patients with previous reactions to ionic contrast material 11 Invest. Radiol. - 1991. - Vol. 26. - P. 411.
424
312. Enright Т. et al. The role of a documented allergic profile as a risk factor for radiographic contrast media reactions // Ann. Allergy. - 1989. - Vol. 62. - P. 302.
313. Greenberger P.A. et al. Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography // J. Allergy Clin. Immunol. - 1987. - Vol. 80. - P. 698.
314. Lang DM. et al. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma // Ann. Intern. Med. - 1991. - Vol. 115. - P. 270.
315. Greenberger P.A. et al. Prophylaxis against repeated radiocontrast media reactions in 857 cases // Arch. Intern. Med. - 1985. - Vol. 145. - P. 2197.
316. Lasser E.C. et al. Pretreatment with corticosteroids to prevent adverse reactions to nonionic contrast media // AJR. - 1994. - Vol. 162. - P. 523.
317. Ramesh S., Reisman R.E. Noncardiogenic pulmonary edema due to radiocontrast media 11 Ann. Allergy Asthma Immunol. - 1995. - Vol. 75. - P. 308.
318. Chandler M.J. et al. Provocative challenge with local anesthetics in patients with a prior history of reaction 11 J. Allergy Clin. Immunol. - 1987. - Vol. 79. - P. 883.
319. deShazo R.D., Nelson H.S. An approach to the patient with a history of local anesthetic hypersensitivity: experience with 90 patients // Ibid. - 1979. - Vol. 63. - P. 387.
320. Incaudo G. et al. Administration of local anesthetics to patients with a history of a prior reaction // Ibid. - 1978.-Vol. 61.-P. 329.
321. Schwartz H.J., Sher Т.Н. Bisulfite sensitivity manifesting as allergy to local dental anesthesia // Ibid. - 1985. - Vol. 75. - P. 525.
322. Pollack C.V., Swindle G.M. Use of diphenhydramine for local anesthesia in «caine’’-sensitive patients 11 J. Emerg. Med. - 1989. - Vol. 7. - P. 611.
323. Patterson R. et al. Insulin allergy: reevaluation after two decades 11 Ann. Allergy. - 1990. -Vol. 64. - P. 459.
324. Fineberg S.H. et al. Immunogenicity of recombinant DNA human insulin // Diabetologia. -
1983.-Vol. 25.-P. 465.
325. Grammer L.C. et al. Cutaneous allergy to human (recombinant DNA) insulin 11 JAMA. - 1984. -Vol. 251.-P. 1459.
326. Grammer L.C. et al. IgE and IgG antibody against human (recombinant DNA) insulin in patients with systemic insulin allergy 11 J. Lab. Clin. Med. - 1985. - Vol. 105. - P. 108.
327. Grammer L.C. et al. Specificity of IgE and IgG against human (recombinant DNA) insulin in human (or DNA) insulin allergy and resistance // J. Lab. Clin. Med. - 1987. - Vol. 109. - P. 141.
328. Yallow R.S., Berson S.A. Immunologic aspects of insulin // Am. I. Med. - 1961. - Vol. 31. -P. 882.
329. Patterson R. et al. Immunologic reactions against insulin. II. IgE anti-insulin and combined IgE and IgG immunologic insulin resistance // J. Immunol. - 1973. - Vol. 110. - P. 1135.
330. deShazo R. et al. Dermal hypersensitivity reaction to insulin: correlations of three patterns to their histopathology 11 J. Allergy Clin. Immunol. - 1982. - Vol. 69. - P. 229.
331. Grammer L.C. et al. Evaluation and management of insulin allergy 11 Ibid. - 1983. - Vol. 71. -P. 250.
332. Mattson J.R. et al. Insulin therapy in patients with systemic insulin allergy 11 Arch. Intern. Med. -1975.-Vol. 135.-P. 818.
333. MeGrath K.G., Patterson R. Anaphylactic reactivity to streptokinase // IAMA. - 1984. -Vol. 252. - P. 1314.
334. MeGrath K.G., Patterson R. Immunology of streptokinase in human subjects 11 Clin. Exp. Immunol. - 1985. - Vol. 62. - P. 421.
335. Dykewicz M.S. et al. Identification of patients at risk for anaphylaxis due to streptokinase // Arch. Intern. Med. - 1986. - Vol. 146. - P. 305
425
336. MeGrath K.G. et al. Allergic reactions to streptokinase consistent with anaphylactic or antigen-antibody complex mediated damage // J. Allergy Clin. Immunol. - 1985. - Vol. 76. - P. 453.
337. Sherry S., Marder V.J. Streptokinase and recombinant tissue plasminogen activatoi (rt-PA) are equally effective in treating acute myocardial infarction // Ann. Intern. Med. - 1991. - Vol. 114. — P. 417.
338. Willis J. (ed.). Chymopapain approval // FDA Drug Bull. - 1982. - Vol. 12. - P. 17.
